Numen

Numen, founded in 2021, operates within the Health Care industry and is headquartered in the United States. With the compelling slogan, "Engineering a future without cancer deaths," the company is poised to make significant strides in addressing critical health challenges.

In a noteworthy step for any early-stage company, Numen secured a $5.00M pre-seed round investment on 01 September 2023. This funding round saw participation from influential investors such as Urban Innovation Fund, Y Combinator, and TQ Ventures, which indicates strong market confidence in the company's vision and potential.

Still in its infancy, Numen is strategically positioning itself to tackle one of humanity's most daunting health issues. As it embarks on the journey to innovate in cancer treatments, its trajectory will be one to watch within the startup ecosystem, especially given the backing of reputable and forward-thinking investors.